{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:18:05Z","timestamp":1786987085658,"version":"build-2736575974"},"reference-count":281,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1163790"],"award-info":[{"award-number":["APP1163790"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02846","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T14:01:42Z","timestamp":1575900102000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["An Inflammatory Story: Antibodies in Tuberculosis Comorbidities"],"prefix":"10.3389","volume":"10","author":[{"given":"Milla R.","family":"McLean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenette L.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report 2018","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S1179","DOI":"10.1093\/infdis\/jir451","article-title":"Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response","volume":"204","author":"Achkar","year":"2011","journal-title":"J Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijid.2019.02.035","article-title":"Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground","author":"Rao","year":"2019","journal-title":"Int J Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.5588\/ijtld.18.0045","article-title":"Convergence of non-communicable diseases and tuberculosis: a two-way street?","volume":"22","author":"Magee","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fpubh.2015.00281","article-title":"HIV-associated TB syndemic: a growing clinical challenge worldwide","volume":"3","author":"Montales","year":"2015","journal-title":"Front Public Health."},{"key":"B7","unstructured":"TB Causes 1 in 3 HIV Deaths2018"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","article-title":"Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis","volume":"29","author":"Gupta","year":"2015","journal-title":"AIDS."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S1473-3099(17)30623-0","article-title":"Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives","volume":"18","author":"Abel","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/bmj.1.4506.677","article-title":"Tuberculosis as a complication of diabetes mellitus","volume":"1","author":"Gauld","year":"1947","journal-title":"Br Med J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1525-139X.2003.03010.x","article-title":"Tuberculosis and chronic renal disease","volume":"16","author":"Hussein","year":"2003","journal-title":"Semin Dial."},{"key":"B12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1473-3099(13)70015-X","article-title":"Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts","volume":"13","author":"Marais","year":"2013","journal-title":"Lancet Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/j.tube.2019.04.015","article-title":"The re-emerging association between tuberculosis and diabetes: lessons from past centuries","author":"Cadena","year":"2019","journal-title":"Tuberculosis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.TNMI7-0023-2016","article-title":"Diabetes and tuberculosis","volume":"4","author":"Restrepo","year":"2016","journal-title":"Microbiol Spectr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41598-019-46455-7","article-title":"Space-time clustering of recently-diagnosed tuberculosis and impact of ART scale-up: evidence from an HIV hyper-endemic rural South African population","volume":"9","author":"Tomita","year":"2019","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz284","article-title":"Diabetes mellitus among pulmonary tuberculosis patients from four TB-endemic countries: the TANDEM study","author":"Ugarte-Gil","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e000380","DOI":"10.1136\/bmjgh-2017-000380","article-title":"Chronic kidney disease and the global NCDs agenda","volume":"2","author":"Neuen","year":"2017","journal-title":"BMJ Glob Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","article-title":"Tuberculosis and chronic kidney disease: an emerging global syndemic","volume":"90","author":"Romanowski","year":"2016","journal-title":"Kidney Int."},{"key":"B20","unstructured":"High level of discordant IGRA results in HIV-infected adults and children41723 MandalakasAM HesselingAC ChegouNN KirchnerHL ZhuX MaraisBJ 18371268Int J Tuberc Lung Dis.122008"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1183\/09031936.00019709","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly?","volume":"33","author":"Lange","year":"2009","journal-title":"Eur Respir J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cell.2016.09.041","article-title":"To be or not be a (functional) antibody against TB","volume":"167","author":"Casadevall","year":"2016","journal-title":"Cell."},{"key":"B25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/cmi.2017.113","article-title":"Th1 cytokines, true functional signatures for protective immunity against TB?","volume":"15","author":"Zeng","year":"2018","journal-title":"Cell Mol Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0190989","DOI":"10.1371\/journal.pone.0190989","article-title":"IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals","volume":"13","author":"Abebe","year":"2018","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN- \u03b3-independent immune markers of Mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1128\/IAI.73.10.6846-6851.2005","article-title":"Antibody profiles characteristic of Mycobacterium tuberculosis infection state","volume":"73","author":"Davidow","year":"2005","journal-title":"Infect Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1348-0421.2012.12005.x","article-title":"Antigen 85A and mycobacterial DNA-binding protein 1 are targets of immunoglobulin G in individuals with past tuberculosis","volume":"57","author":"Osada-Oka","year":"2013","journal-title":"Microbiol Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jinf.2014.05.014","article-title":"Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets","volume":"69","author":"Baumann","year":"2014","journal-title":"J Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.diagmicrobio.2015.07.021","article-title":"Diagnostic value of antibody responses to multiple antigens from Mycobacterium tuberculosis in active and latent tuberculosis","volume":"83","author":"Senoputra","year":"2015","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"37525","DOI":"10.18632\/oncotarget.16401","article-title":"Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB","volume":"8","author":"Awoniyi","year":"2017","journal-title":"Oncotarget."},{"key":"B36","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/cid\/cix023","article-title":"Diagnostic performance of tuberculosis-specific IgG antibody profiles in patients with presumptive tuberculosis from two continents","volume":"64","author":"Broger","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.tube.2017.10.010","article-title":"IgG subclasses' response to a set of mycobacterial antigens in different stages of Mycobacterium tuberculosis infection","volume":"108","author":"De Araujo","year":"2018","journal-title":"Tuberculosis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0205102","DOI":"10.1371\/journal.pone.0205102","article-title":"Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance","volume":"13","author":"Kimuda","year":"2018","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tube.2019.03.005","article-title":"Immunoscreening of the M. tuberculosis F15\/LAM4\/KZN secretome library against TB patients' sera identifies unique active- and latent-TB specific biomarkers","volume":"115","author":"Chiliza","year":"2019","journal-title":"Tuberculosis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/1348-0421.12674","article-title":"Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection","volume":"63","author":"Maekura","year":"2019","journal-title":"Microbiol Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(08)60486-1","article-title":"Human antibody effector function","volume":"51","author":"Burton","year":"1992","journal-title":"Adv Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0952-7915(02)00409-0","article-title":"Fc receptors are major mediators of antibody based inflammation in autoimmunity","volume":"14","author":"Hogarth","year":"2002","journal-title":"Curr Opin Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4049\/jimmunol.1400844","article-title":"Natural antibodies bridge innate and adaptive immunity","volume":"194","author":"Panda","year":"2015","journal-title":"J Immunol."},{"key":"B44","first-page":"383","article-title":"IgA subclasses in various secretions and in serum","volume":"47","author":"Delacroix","year":"1982","journal-title":"Immunology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-2567.2004.01958.x","article-title":"IgA function\u2013variations on a theme","volume":"113","author":"Woof","year":"2004","journal-title":"Immunology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","article-title":"Role of IgG3 in infectious diseases","volume":"40","author":"Damelang","year":"2019","journal-title":"Trends Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevImmunol.v30.i1.10","article-title":"Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses","volume":"30","author":"Pone","year":"2010","journal-title":"Crit Rev Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1084\/jem.181.3.1239","article-title":"gamma\/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes","volume":"181","author":"Horner","year":"1995","journal-title":"J Exp Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0952-7915(96)80058-6","article-title":"Immunoglobulin class switching","volume":"8","author":"Stavnezer","year":"1996","journal-title":"Curr Opin Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"16097","DOI":"10.1073\/pnas.1303218110","article-title":"Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides","volume":"110","author":"Bai","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B52","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.128.4.1772","article-title":"The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation","volume":"128","author":"Tarr","year":"1982","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"S537","DOI":"10.1093\/clinids\/9.Supplement_5.S537","article-title":"The function of antibody and complement in the lysis of bacteria","volume":"9","author":"Frank","year":"1987","journal-title":"Rev Infect Dis."},{"key":"B54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4049\/jimmunol.138.2.587","article-title":"Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide","volume":"138","author":"Shackelford","year":"1987","journal-title":"J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/00006454-199008001-00004","article-title":"IgG subclass distribution of antibodies to bacterial and viral antigens","volume":"9","author":"Ferrante","year":"1990","journal-title":"Pediatr Infect Dis J."},{"key":"B56","first-page":"391","article-title":"Host defenses to extracellular bacteria","volume-title":"Clinical Immunology: Principles and Practice","author":"Schechter","year":"2018"},{"key":"B57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature."},{"key":"B58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12977-018-0438-x","article-title":"Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies","volume":"15","author":"Parsons","year":"2018","journal-title":"Retrovirology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.bbrc.2007.02.042","article-title":"A broad range of Fab stabilities within a host of therapeutic IgGs","volume":"355","author":"Garber","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1074\/mcp.M900540-MCP200","article-title":"Post-translational modifications differentially affect IgG1 conformation and receptor binding","volume":"9","author":"Houde","year":"2010","journal-title":"Mol Cell Proteomics."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nbt1252","article-title":"Post-translational modifications in the context of therapeutic proteins","volume":"24","author":"Walsh","year":"2006","journal-title":"Nat Biotechnol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1097\/QAD.0000000000000444","article-title":"Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function","volume":"28","author":"Chung","year":"2014","journal-title":"AIDS."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The emerging importance of IgG fab glycosylation in immunity","volume":"196","author":"Van De Bovenkamp","year":"2016","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/glycob\/cwx036","article-title":"The direct and indirect effects of glycans on immune function","volume":"27","author":"Baum","year":"2017","journal-title":"Glycobiology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1155\/2008\/493289","article-title":"Glycosylation of serum proteins in inflammatory diseases","volume":"25","author":"Gornik","year":"2008","journal-title":"Dis Markers."},{"key":"B66","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4161\/mabs.28808","article-title":"Highly parallel characterization of IgG Fc binding interactions","volume":"6","author":"Boesch","year":"2014","journal-title":"MAbs."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0143520","DOI":"10.1371\/journal.pone.0143520","article-title":"Multi-angle effector function analysis of human monoclonal IgG glycovariants","volume":"10","author":"Dashivets","year":"2015","journal-title":"PLoS ONE."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/2211-5463.12283","article-title":"Rapid screening of IgG quality attributes - effects on Fc receptor binding","volume":"7","author":"Geuijen","year":"2017","journal-title":"FEBS Open Bio."},{"key":"B69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/6179","article-title":"Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity","volume":"17","author":"Umana","year":"1999","journal-title":"Nat Biotechnol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1007\/s10875-010-9405-6","article-title":"A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs","volume":"30","author":"Anthony","year":"2010","journal-title":"J Clin Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"eaat7796","DOI":"10.1126\/sciimmunol.aat7796","article-title":"Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement","volume":"3","author":"Lofano","year":"2018","journal-title":"Sci Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1073\/pnas.1711720115","article-title":"Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region","volume":"115","author":"Van De Bovenkamp","year":"2018","journal-title":"PNAS."},{"key":"B75","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/eji.1830071213","article-title":"Reconstitution of natural cell-mediated cytotoxicity with specific antibodies","volume":"7","author":"Takasugi","year":"1977","journal-title":"Eur J Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0923-2494(90)90017-S","article-title":"Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells","volume":"141","author":"Clement","year":"1990","journal-title":"Res Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood."},{"key":"B78","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fimmu.2019.00464","article-title":"The human FcgammaRII (CD32) family of leukocyte FcR in health and disease","volume":"10","author":"Anania","year":"2019","journal-title":"Front Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrd2909","article-title":"Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond","volume":"11","author":"Hogarth","year":"2012","journal-title":"Nat Rev Drug Discov."},{"key":"B80","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.arcmed.2004.05.008","article-title":"Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases","volume":"35","author":"Ilgazli","year":"2004","journal-title":"Arch Med Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"213sr216","DOI":"10.1126\/scitranslmed.3007402","article-title":"TB or not TB: that is no longer the question","volume":"5","author":"Modlin","year":"2013","journal-title":"Sci Transl. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/00313029009063555","article-title":"Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies","volume":"22","author":"Randhawa","year":"1990","journal-title":"Pathology."},{"key":"B86","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1128\/IAI.67.7.3242-3247.1999","article-title":"Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis","volume":"67","author":"Feng","year":"1999","journal-title":"Infect Immun."},{"key":"B87","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0167-5699(98)01321-8","article-title":"Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria","volume":"19","author":"Ottenhoff","year":"1998","journal-title":"Immunol Today."},{"key":"B88","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/1756-185X.12188","article-title":"Risk of tuberculosis with anti-tumor necrosis factor-alpha therapy: substantially higher number of patients at risk in Asia","volume":"17","author":"Navarra","year":"2014","journal-title":"Int J Rheum Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jmii.2013.03.005","article-title":"Risk of tuberculosis infection in anti-TNF-alpha biological therapy: from bench to bedside","volume":"47","author":"Xie","year":"2014","journal-title":"J Microbiol Immunol Infect."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1371\/journal.pmed.0050145","article-title":"Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations","volume":"5","author":"Hanekom","year":"2008","journal-title":"PLoS Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J Infect Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1473-3099(11)70146-3","article-title":"Fact and fiction in tuberculosis vaccine research: 10 years later","volume":"11","author":"Kaufmann","year":"2011","journal-title":"Lancet Infect Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.4049\/jimmunol.1001222","article-title":"TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis","volume":"185","author":"Du","year":"2010","journal-title":"J Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2567.2001.01305.x","article-title":"Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation","volume":"104","author":"Leal","year":"2001","journal-title":"Immunology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T cell-derived IFN-gamma plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PLoS Pathog."},{"key":"B97","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/517479","article-title":"Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis","volume":"178","author":"Bekker","year":"1998","journal-title":"J Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cmi.2017.12.003","article-title":"Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment","volume":"24","author":"Picchi","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B99","doi-asserted-by":"publisher","first-page":"eaat2702","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy","volume":"11","author":"Barber","year":"","journal-title":"Sci. Transl. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease","volume":"17","author":"Harari","year":"2011","journal-title":"Nat Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fimmu.2019.00431","article-title":"Mycobacteria-specific mono- and polyfunctional CD4+ T cell profiles in children with latent and active tuberculosis: a prospective proof-of-concept study","volume":"10","author":"Tebruegge","year":"2019","journal-title":"Front Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"11290","DOI":"10.1038\/ncomms11290","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat Commun."},{"key":"B104","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/IAI.65.5.1936-1938.1997","article-title":"Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages","volume":"65","author":"Ladel","year":"1997","journal-title":"Infect Immun."},{"key":"B105","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","article-title":"Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis","volume":"192","author":"Tebruegge","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tube.2018.08.011","article-title":"Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting","volume":"114","author":"Clifford","year":"2019","journal-title":"Tuberculosis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4110\/in.2017.17.1.25","article-title":"Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies","volume":"17","author":"Kim","year":"2017","journal-title":"Immune Netw."},{"key":"B108","doi-asserted-by":"publisher","first-page":"E2322","DOI":"10.3390\/ijms20092322","article-title":"Inflammatory and molecular pathways in heart failure-ischemia, HFpEF and transthyretin cardiac amyloidosis","volume":"20","author":"Michels Da Silva","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1365-2249.2000.01139.x","article-title":"PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis","volume":"119","author":"Hussain","year":"2000","journal-title":"Clin Exp Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1365-2249.2001.01439.x","article-title":"Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis","volume":"123","author":"Hussain","year":"2001","journal-title":"Clin Exp Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3899\/jrheum.140103","article-title":"Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-alpha (TNF-alpha) targeted biologics and recently licensed TNF-alpha inhibitors: data from clinical trials and national registries","volume":"91","author":"Cantini","year":"2014","journal-title":"J Rheumatol Suppl."},{"key":"B112","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1038\/s41598-019-50847-0","article-title":"M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis","volume":"9","author":"Essone","year":"2019","journal-title":"Sci Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e12665","DOI":"10.1111\/sji.12665","article-title":"A hypothesis for the existence of two types of tuberculosis, reflecting two distinct types of immune failure to control the pathogen, based upon prevalence of mycobacterium-specific IgG subclasses","volume":"87","author":"Menon","year":"2018","journal-title":"Scand J Immunol."},{"key":"B114","first-page":"230","article-title":"The spectrum of human tuberculosis","volume":"27","author":"Lenzini","year":"1977","journal-title":"Clin Exp Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1128\/CVI.00503-09","article-title":"Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status","volume":"17","author":"Achkar","year":"2010","journal-title":"Clin Vaccine Immunol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/CDLI.2.6.726-732.1995","article-title":"Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients","volume":"2","author":"Hussain","year":"1995","journal-title":"Clin Diagn Lab Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1365-2249.1998.00452.x","article-title":"IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients","volume":"111","author":"Sousa","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tube.2015.11.001","article-title":"Detection of IgG1 antibodies against Mycobacterium tuberculosis DosR and Rpf antigens in tuberculosis patients before and after chemotherapy","volume":"96","author":"Mattos","year":"2016","journal-title":"Tuberculosis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/eji.1830210103","article-title":"Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration","volume":"21","author":"Michaelsen","year":"1991","journal-title":"Eur J Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"92340","DOI":"10.1371\/journal.pone.0092340","article-title":"Increased complement C1q level marks active disease in human tuberculosis","volume":"9","author":"Cai","year":"2014","journal-title":"PLoS ONE."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e1006687","DOI":"10.1371\/journal.ppat.1006687","article-title":"Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease","volume":"13","author":"Scriba","year":"2017","journal-title":"PLoS Pathog."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3389\/fimmu.2018.02427","article-title":"Complement component C1q as serum biomarker to detect active tuberculosis","volume":"9","author":"Lubbers","year":"2018","journal-title":"Front Immunol."},{"key":"B123","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/IAI.13.5.1301-1306.1976","article-title":"Enhancement activity of anti-mycobacterial sera in experimental Mycobacterium bovis (BCG) infection in mice","volume":"13","author":"Forget","year":"1976","journal-title":"Infect Immun."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1128\/JCM.42.7.3225-3231.2004","article-title":"Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan","volume":"42","author":"Glatman-Freedman","year":"2004","journal-title":"J Clin Microbiol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1128\/IAI.73.9.6101-6109.2005","article-title":"Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice","volume":"73","author":"Roy","year":"2005","journal-title":"Infect Immun."},{"key":"B127","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/2049-632X.12069","article-title":"The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation","volume":"69","author":"Olivares","year":"2013","journal-title":"Pathog Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1378\/chest.94.1.133","article-title":"The detection by immunoassay of antibody to mycobacterial antigens and mycobacterial antigens in bronchoalveolar lavage fluid from patients with tuberculosis and control subjects","volume":"94","author":"Raja","year":"1988","journal-title":"Chest."},{"key":"B129","unstructured":"Humoral immune response against mycobacterial antigens in bronchoalveolar fluid from tuberculosis patients84 DemkowU Bialas-ChromiecB FilewskaM SobieckaM KusJ SzturmowiczM 16204779J Physiol Pharmacol.792005"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.4049\/jimmunol.1500981","article-title":"Role of B cells in mucosal vaccine-induced protective CD8+ T cell immunity against pulmonary tuberculosis","volume":"195","author":"Khera","year":"2015","journal-title":"J Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.imlet.2006.04.014","article-title":"In search of the elusive mouse macrophage Fc-alpha receptor","volume":"107","author":"Reljic","year":"2006","journal-title":"Immunol Lett."},{"key":"B132","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.vaccine.2004.11.032","article-title":"Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG","volume":"23","author":"Rodriguez","year":"2005","journal-title":"Vaccine"},{"key":"B134","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ijmm.2008.10.007","article-title":"Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection","volume":"299","author":"Lopez","year":"2009","journal-title":"Int J Med Microbiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrrheum.2017.146","article-title":"Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?","volume":"13","author":"Seeling","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/gut.31.4.431","article-title":"Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein","volume":"31","author":"Dube","year":"1990","journal-title":"Gut."},{"key":"B137","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.11.041","article-title":"Engineered sialylation of pathogenic antibodies in vivo attenuates autoimmune disease","volume":"172","author":"Pagan","year":"2018","journal-title":"Cell."},{"key":"B138","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1146\/annurev-immunol-042617-053420","article-title":"The immune response to Mycobacterium tuberculosis in HIV-1-coinfected persons","volume":"36","author":"Esmail","year":"2018","journal-title":"Annu Rev Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1016\/j.molimm.2007.02.005","article-title":"Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity","volume":"44","author":"Masuda","year":"2007","journal-title":"Mol Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41586-018-0439-x","article-title":"A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes","volume":"560","author":"Roy Chowdhury","year":"2018","journal-title":"Nature."},{"key":"B141","doi-asserted-by":"publisher","first-page":"29080","DOI":"10.1074\/jbc.M504528200","article-title":"Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin","volume":"280","author":"Arnold","year":"2005","journal-title":"J Biol Chem."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s13361-016-1378-0","article-title":"Site-specific N-glycosylation of recombinant pentameric and hexameric human IgM","volume":"27","author":"Moh","year":"2016","journal-title":"J Am Soc Mass Spectrom."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e00684","DOI":"10.1128\/mSphere.00684-18","article-title":"Serum IgM glycosylation associated with tuberculosis infection in mice","volume":"4","author":"Kumagai","year":"2019","journal-title":"mSphere."},{"key":"B144","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.4049\/jimmunol.180.5.3329","article-title":"Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection","volume":"180","author":"Maglione","year":"2008","journal-title":"J Immunol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"O230","DOI":"10.1111\/1469-0691.12383","article-title":"Differential gene expression of activating Fcgamma receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity","volume":"20","author":"Sutherland","year":"2014","journal-title":"Clin Microbiol Infect."},{"key":"B146","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response","volume":"207","author":"Cliff","year":"2013","journal-title":"J Infect Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1084\/jem.109.6.523","article-title":"Studies on tubercle bacillus-monocyte relationship. III Conditions affecting the action of serum and cells; modification of bacilli in an immune system","volume":"109","author":"Fong","year":"1959","journal-title":"J Exp Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.142.1.1","article-title":"Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival","volume":"142","author":"Armstrong","year":"1975","journal-title":"J Exp Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of human antibodies to Arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis."},{"key":"B150","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies","volume":"73","author":"De Valliere","year":"2005","journal-title":"Infect Immun."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI38482","article-title":"Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans","volume":"119","author":"Bruns","year":"2009","journal-title":"J Clin Invest."},{"key":"B152","doi-asserted-by":"publisher","first-page":"20441","DOI":"10.1073\/pnas.1013827107","article-title":"Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting","volume":"107","author":"Joller","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B153","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ni.2474","article-title":"Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta","volume":"14","author":"Mishra","year":"2013","journal-title":"Nat Immunol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.molmed.2016.10.008","article-title":"Bacterial pathogens versus autophagy: implications for therapeutic interventions","volume":"22","author":"Kimmey","year":"2016","journal-title":"Trends Mol Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"15688","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B156","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1056\/NEJMra1011874","article-title":"Acute HIV-1 infection","volume":"364","author":"Cohen","year":"2011","journal-title":"N Engl J Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathog."},{"key":"B159","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4314\/ahs.v18i3.7","article-title":"Effect of anti-retroviral therapy on oxidative stress in hospitalized HIV-infected adults with and without TB","volume":"18","author":"Musisi","year":"2018","journal-title":"Afr Health Sci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/infdis\/jiz252","article-title":"Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy","volume":"220","author":"Kroeze","year":"2019","journal-title":"J Infect Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"E1390","DOI":"10.3390\/ijms18071390","article-title":"Macrophages and phospholipases at the intersection between inflammation and the pathogenesis of HIV-1 infection","volume":"18","author":"Spadaro","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ebiom.2018.03.024","article-title":"Fecal microbiota composition drives immune activation in HIV-infected individuals","volume":"30","author":"Neff","year":"2018","journal-title":"EBioMedicine."},{"key":"B163","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/infdis\/jiy244","article-title":"Increased systemic inflammation and gut permeability among women with treated HIV infection in rural Uganda","volume":"218","author":"Siedner","year":"2018","journal-title":"J Infect Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/COH.0000000000000275","article-title":"Does systemic inflammation and immune activation contribute to fracture risk in HIV?","volume":"11","author":"Mcginty","year":"2016","journal-title":"Curr Opin HIV AIDS."},{"key":"B165","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/15284336.2017.1366001","article-title":"Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection","volume":"18","author":"Dirajlal-Fargo","year":"2017","journal-title":"HIV Clin Trials."},{"key":"B166","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijid.2018.11.214","article-title":"Markers of systemic inflammation in HIV-infected patients with different HIV RNA level","volume":"79","author":"Matuzkova","year":"2019","journal-title":"Int J Infect Dis."},{"key":"B167","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/QAD.0b013e3283453fcb","article-title":"Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV","volume":"25","author":"Musselwhite","year":"2011","journal-title":"AIDS."},{"key":"B168","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/BIC.S15056","article-title":"Biomarkers of HIV-associated cancer","volume":"6","author":"Flepisi","year":"2014","journal-title":"Biomark Cancer."},{"key":"B170","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev-med-052912-123749","article-title":"Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection","volume":"66","author":"Kim","year":"2015","journal-title":"Annu Rev Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med."},{"key":"B172","doi-asserted-by":"publisher","first-page":"228ra238","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Transl Med."},{"key":"B173","doi-asserted-by":"publisher","first-page":"228ra239","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci Transl Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell."},{"key":"B175","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/COH.0b013e328363d486","article-title":"New paradigms for functional HIV-specific nonneutralizing antibodies","volume":"8","author":"Forthal","year":"2013","journal-title":"Curr Opin HIV AIDS."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.4049\/jimmunol.174.4.2185","article-title":"Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251","volume":"174","author":"Gomez-Roman","year":"2005","journal-title":"J Immunol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/QAI.0b013e3182874d41","article-title":"Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection","volume":"63","author":"Forthal","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B178","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/QAD.0000000000001716","article-title":"Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors","volume":"32","author":"Sadanand","year":"2018","journal-title":"AIDS."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/infdis\/155.6.1113","article-title":"Antibody response to human immunodeficiency virus after primary infection","volume":"155","author":"Cooper","year":"1987","journal-title":"J Infect Dis."},{"key":"B180","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J Virol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B182","doi-asserted-by":"publisher","first-page":"e1001251","DOI":"10.1371\/journal.ppat.1001251","article-title":"Characteristics of the earliest cross-neutralizing antibody response to HIV-1","volume":"7","author":"Mikell","year":"2011","journal-title":"PLoS Pathog."},{"key":"B183","doi-asserted-by":"publisher","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B184","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0091-6749(88)90132-7","article-title":"The relationship of serum IgA concentration to human immunodeficiency virus (HIV) infection: a cross-sectional study of HIV-seropositive individuals detected by screening in the United States Air Force","volume":"82","author":"Fling","year":"1988","journal-title":"J Allergy Clin Immunol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0895-4356(92)90084-Z","article-title":"Using serial observations to identify predictors of progression to AIDS in the Toronto Sexual Contact Study","volume":"45","author":"Coates","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1089\/aid.2018.0099","article-title":"The multifaceted nature of immunoglobulin A and its complex role in HIV","volume":"34","author":"Lopez","year":"2018","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B187","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/QAD.0b013e32834b348e","article-title":"Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection","volume":"25","author":"Yates","year":"2011","journal-title":"AIDS."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1002\/eji.201344305","article-title":"Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection","volume":"44","author":"Dugast","year":"2014","journal-title":"Eur J Immunol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4049\/jimmunol.1602161","article-title":"Dimeric fcgamma receptor enzyme-linked immunosorbent assay to study HIV-specific antibodies: a new look into breadth of fcgamma receptor antibodies induced by the RV144 vaccine trial","volume":"199","author":"Mclean","year":"2017","journal-title":"J Immunol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1097\/QAD.0000000000001242","article-title":"Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24","volume":"30","author":"Tjiam","year":"2016","journal-title":"AIDS."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/QAD.0000000000001812","article-title":"Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity","volume":"32","author":"Chung","year":"2018","journal-title":"AIDS."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/cid\/cix057","article-title":"Virus-driven inflammation is associated with the development of bNAbs in spontaneous controllers of HIV","volume":"64","author":"Dugast","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B193","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest."},{"key":"B194","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/01.aids.0000161767.21405.68","article-title":"Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals","volume":"19","author":"Moore","year":"2005","journal-title":"AIDS."},{"key":"B195","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/JLB.3HI1217-500R","article-title":"Frontline science: plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy","volume":"104","author":"Vadrevu","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B196","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.157.5.2168","article-title":"HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression","volume":"157","author":"Baum","year":"1996","journal-title":"J Immunol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1086\/314988","article-title":"Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients","volume":"180","author":"Forthal","year":"1999","journal-title":"J Infect Dis."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.4049\/jimmunol.182.2.1202","article-title":"Rapid degranulation of NK cells following activation by HIV-specific antibodies","volume":"182","author":"Chung","year":"2009","journal-title":"J Immunol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/QAI.0b013e31822c62b9","article-title":"Activation of NK cells by ADCC antibodies and HIV disease progression","volume":"58","author":"Chung","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B200","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/COH.0000000000000439","article-title":"Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?","volume":"13","author":"Lee","year":"2018","journal-title":"Curr Opin HIV AIDS."},{"key":"B201","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.1016048108","article-title":"Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure","volume":"108","author":"Chung","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B202","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/vim.2011.0025","article-title":"NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients","volume":"24","author":"Johansson","year":"2011","journal-title":"Viral Immunol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/imm.12016","article-title":"Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection","volume":"138","author":"Wren","year":"2013","journal-title":"Immunology."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/mi.2016.12","article-title":"Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies","volume":"9","author":"Sips","year":"2016","journal-title":"Mucosal Immunol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jim.2018.03.007","article-title":"Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC","volume":"457","author":"Worley","year":"2018","journal-title":"J Immunol Methods."},{"key":"B206","doi-asserted-by":"publisher","first-page":"e1005315","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control","volume":"12","author":"Ackerman","year":"2016","journal-title":"PLoS Pathog."},{"key":"B207","doi-asserted-by":"publisher","first-page":"e1006987","DOI":"10.1371\/journal.ppat.1006987","article-title":"HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies","volume":"14","author":"Richardson","year":"2018","journal-title":"PLoS Pathog."},{"key":"B208","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12929-018-0490-9","article-title":"The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects","volume":"25","author":"Osuji","year":"2018","journal-title":"J Biomed Sci."},{"key":"B209","doi-asserted-by":"publisher","first-page":"166","DOI":"10.11604\/pamj.2018.31.166.17294","article-title":"The role of Mycobacterium tuberculosis antigen specific cytokines in determination of acid fast bacilli culture status in pulmonary tuberculosis patients co-infected with human immunodeficiency virus","volume":"31","author":"Kisuya","year":"2018","journal-title":"Pan Afr Med J."},{"key":"B210","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1086\/426827","article-title":"How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners","volume":"191","author":"Sonnenberg","year":"2005","journal-title":"J Infect Dis."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.5588\/ijtld.13.0032","article-title":"Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa","volume":"17","author":"Gupta","year":"2013","journal-title":"Int J Tuberc Lung Dis."},{"key":"B212","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12879-018-3256-9","article-title":"HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town","volume":"18","author":"Kaplan","year":"2018","journal-title":"BMC Infect Dis."},{"key":"B213","doi-asserted-by":"publisher","first-page":"125810","DOI":"10.1172\/JCI125810","article-title":"Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection","volume":"129","author":"Bucsan","year":"2019","journal-title":"J Clin Invest."},{"key":"B214","doi-asserted-by":"publisher","first-page":"e9611","DOI":"10.1371\/journal.pone.0009611","article-title":"Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load","volume":"5","author":"Diedrich","year":"2010","journal-title":"PLoS ONE."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1086\/517636","article-title":"Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy","volume":"26","author":"Crump","year":"1998","journal-title":"Clin Infect Dis."},{"key":"B216","unstructured":"Unmasking tuberculosis-associated immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy2069 PornprasertS LeechanachaiP KlinbuayaemV LeenasirimakulP PrompingC IntaP 21038792Asian Pac J Allergy Immunol.282010"},{"key":"B217","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/QAD.0000000000000557","article-title":"Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"29","author":"Tan","year":"2015","journal-title":"AIDS."},{"key":"B218","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis."},{"key":"B219","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/COH.0000000000000502","article-title":"The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research","volume":"13","author":"Walker","year":"2018","journal-title":"Curr Opin HIV AIDS."},{"key":"B220","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-6405-4-9","article-title":"Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options","volume":"4","author":"Murdoch","year":"2007","journal-title":"AIDS Res Ther."},{"key":"B221","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1074\/mcp.M600089-MCP200","article-title":"Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling","volume":"5","author":"Sartain","year":"2006","journal-title":"Mol Cell Proteomics."},{"key":"B222","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/CVI.05550-11","article-title":"Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status","volume":"19","author":"Yu","year":"2012","journal-title":"Clin Vaccine Immunol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1128\/IAI.69.7.4600-4609.2001","article-title":"Homogeneity of antibody responses in tuberculosis patients","volume":"69","author":"Samanich","year":"2001","journal-title":"Infect Immun."},{"key":"B224","doi-asserted-by":"publisher","first-page":"00115","DOI":"10.1183\/23120541.00115-2018","article-title":"Biomarkers for tuberculosis: the case for lipoarabinomannan","volume":"5","author":"Correia-Neves","year":"2019","journal-title":"ERJ Open Res."},{"key":"B225","doi-asserted-by":"publisher","first-page":"e78165","DOI":"10.1371\/journal.pone.0078165","article-title":"Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa","volume":"8","author":"Machado","year":"2013","journal-title":"PLoS ONE."},{"key":"B226","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1099\/00222615-44-3-165","article-title":"IgA and IgG antibodies to distinct serotypes of Mycobacterium avium in HIV seropositivity and AIDS","volume":"44","author":"Hernandez-Munoz","year":"1996","journal-title":"J Med Microbiol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology."},{"key":"B228","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm.2001","article-title":"Normalization of obesity-associated insulin resistance through immunotherapy","volume":"15","author":"Winer","year":"2009","journal-title":"Nat Med."},{"key":"B229","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1373\/clinchem.2010.148833","article-title":"Therapeutic approaches to target inflammation in type 2 diabetes","volume":"57","author":"Goldfine","year":"2011","journal-title":"Clin Chem."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00125-010-1730-z","article-title":"Toll-like receptors regulate B cell cytokine production in patients with diabetes","volume":"53","author":"Jagannathan","year":"2010","journal-title":"Diabetologia."},{"key":"B231","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res Clin Pract."},{"key":"B232","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/0300060513516944","article-title":"Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus","volume":"42","author":"Sefil","year":"2014","journal-title":"J Int Med Res."},{"key":"B233","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1159\/000443073","article-title":"Elevated B cell activation is associated with type 2 diabetes development in obese subjects","volume":"38","author":"Zhai","year":"2016","journal-title":"Cell Physiol Biochem."},{"key":"B234","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/eji.201343822","article-title":"Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts","volume":"44","author":"Heine","year":"2014","journal-title":"Eur J Immunol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11892-017-0900-5","article-title":"T cell populations and functions are altered in human obesity and type 2 diabetes","volume":"17","author":"Touch","year":"2017","journal-title":"Curr Diab Rep."},{"key":"B237","doi-asserted-by":"publisher","first-page":"6494795","DOI":"10.1155\/2017\/6494795","article-title":"Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation","volume":"2017","author":"Xia","year":"2017","journal-title":"J Diabetes Res."},{"key":"B238","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1161\/ATVBAHA.114.304636","article-title":"T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans","volume":"34","author":"Mclaughlin","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/oby.21243","article-title":"Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFalpha production","volume":"24","author":"Ip","year":"2016","journal-title":"Obesity."},{"key":"B240","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front Immunol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-013-0388-2","article-title":"Macrophages in tuberculosis: friend or foe","volume":"35","author":"Guirado","year":"2013","journal-title":"Semin Immunopathol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"196297","DOI":"10.1155\/2015\/196297","article-title":"Identification of anti-long chain saturated fatty acid igg antibodies in serum of patients with type 2 diabetes","volume":"2015","author":"Nicholas","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B243","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nm.2353","article-title":"B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies","volume":"17","author":"Winer","year":"2011","journal-title":"Nat Med."},{"key":"B244","doi-asserted-by":"publisher","first-page":"e2922","DOI":"10.1002\/dmrr.2922","article-title":"Autoantibodies against PFDN2 are associated with an increased risk of type 2 diabetes: a case-control study","volume":"33","author":"Chang","year":"2017","journal-title":"Diabetes Metab Res Rev."},{"key":"B245","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nm0511-539","article-title":"The B-side story in insulin resistance","volume":"17","author":"Mallat","year":"2011","journal-title":"Nat Med."},{"key":"B246","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/ard.47.7.536","article-title":"An IgG subclass imbalance in connective tissue disease","volume":"47","author":"Kay","year":"1988","journal-title":"Ann Rheum Dis."},{"key":"B247","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1097\/MD.0000000000000387","article-title":"Serum IgG subclasses in autoimmune diseases","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine."},{"key":"B248","doi-asserted-by":"publisher","first-page":"OR01","DOI":"10.7860\/JCDR\/2017\/22749.9398","article-title":"SLE and tuberculosis: a case series and review of literature","volume":"11","author":"Bhattacharya","year":"2017","journal-title":"J Clin Diagn Res."},{"key":"B249","doi-asserted-by":"publisher","first-page":"13616","DOI":"10.1038\/s41598-018-32108-8","article-title":"Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study","volume":"8","author":"Fiorentino","year":"2018","journal-title":"Sci Rep."},{"key":"B250","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1172\/JCI89333","article-title":"Hyposialylated IgG activates endothelial IgG receptor FcgammaRIIB to promote obesity-induced insulin resistance","volume":"128","author":"Tanigaki","year":"2018","journal-title":"J Clin Invest."},{"key":"B251","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.bbagen.2017.06.020","article-title":"IgG glycan patterns are associated with type 2 diabetes in independent European populations","volume":"1861","author":"Lemmers","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"B252","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/glycob\/cwu057","article-title":"Glycoxidation of biological macromolecules: a critical approach to halt the menace of glycation","volume":"24","author":"Ahmad","year":"2014","journal-title":"Glycobiology."},{"key":"B253","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cccn.2004.04.016","article-title":"Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy","volume":"347","author":"Kalia","year":"2004","journal-title":"Clin Chim Acta."},{"key":"B254","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12291-009-0029-7","article-title":"Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy","volume":"24","author":"Mistry","year":"2009","journal-title":"Indian J Clin Biochem."},{"key":"B255","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1513\/AnnalsATS.201305-112OC","article-title":"Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines","volume":"10","author":"Kumar","year":"2013","journal-title":"Ann Am Thorac Soc."},{"key":"B256","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ebiom.2018.05.011","article-title":"Patients with concurrent tuberculosis and diabetes have a pro-atherogenic plasma lipid profile","volume":"32","author":"Vrieling","year":"2018","journal-title":"EBioMedicine."},{"key":"B257","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","article-title":"Influence of diabetes mellitus on immunity to human tuberculosis","volume":"152","author":"Kumar Nathella","year":"2017","journal-title":"Immunology."},{"key":"B258","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41598-017-01767-4","article-title":"Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications","volume":"7","author":"Prada-Medina","year":"2017","journal-title":"Sci Rep."},{"key":"B259","unstructured":"Impact of diabetes on mechanisms of immunity against Mycobacterium tuberculosis948 RaoS RahimM IqbalK HaroonF HasanZ 30623920J Pak Med Assoc.692019"},{"key":"B260","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tube.2012.10.003","article-title":"Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control","volume":"93","author":"Gomez","year":"2013","journal-title":"Tuberculosis."},{"key":"B261","doi-asserted-by":"publisher","first-page":"e92977","DOI":"10.1371\/journal.pone.0092977","article-title":"Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia","volume":"9","author":"Restrepo","year":"2014","journal-title":"PLoS ONE."},{"key":"B262","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","article-title":"Immune dysfunction and risk of infection in chronic kidney disease","volume":"26","author":"Syed-Ahmed","year":"2019","journal-title":"Adv Chronic Kidney Dis."},{"key":"B263","doi-asserted-by":"publisher","first-page":"597","DOI":"10.7326\/0003-4819-93-4-597","article-title":"Host defenses and immunologic alterations associated with chronic hemodialysis","volume":"93","author":"Goldblum","year":"1980","journal-title":"Ann Intern Med."},{"key":"B264","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/pmj.78.923.538","article-title":"Vaccination against hepatitis B infection in patients with end stage renal disease","volume":"78","author":"Bel'eed","year":"2002","journal-title":"Postgrad Med J."},{"key":"B266","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.vaccine.2019.05.036","article-title":"Natural immunity against Haemophilus influenzae type a and B-cell subpopulations in adult patients with severe chronic kidney disease","volume":"37","author":"Gaultier","year":"2019","journal-title":"Vaccine."},{"key":"B267","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00005-019-00548-3","article-title":"CTLA-4 expression inversely correlates with kidney function and serum immunoglobulin concentration in patients with primary glomerulonephritides","volume":"67","author":"Grywalska","year":"2019","journal-title":"Arch Immunol Ther Exp."},{"key":"B268","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.13119","article-title":"The role of the immune system in kidney disease","volume":"192","author":"Tecklenborg","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1681\/ASN.2015010109","article-title":"Glycosylation profile of IgG in moderate kidney dysfunction","volume":"27","author":"Barrios","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1681\/ASN.2011080822","article-title":"Fcgamma receptor deficiency attenuates diabetic nephropathy","volume":"23","author":"Lopez-Parra","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B271","doi-asserted-by":"publisher","first-page":"e0213215","DOI":"10.1371\/journal.pone.0213215","article-title":"Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity","volume":"14","author":"Lardinois","year":"2019","journal-title":"PLoS ONE."},{"key":"B272","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2016.05.004","article-title":"Maintenance of Mycobacterium tuberculosis-specific T cell responses in End Stage Renal Disease (ESRD) and implications for diagnostic efficacy","volume":"168","author":"Juno","year":"2016","journal-title":"Clin Immunol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.kint.2017.03.036","article-title":"gammadelta T-cell function is inhibited in end-stage renal disease and impacted by latent tuberculosis infection","volume":"92","author":"Juno","year":"2017","journal-title":"Kidney Int."},{"key":"B274","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3389\/fimmu.2018.01076","article-title":"Mucosal-associated invariant T cells are depleted and exhibit altered chemokine receptor expression and elevated granulocyte macrophage-colony stimulating factor production during end-stage renal disease","volume":"9","author":"Juno","year":"2018","journal-title":"Front Immunol."},{"key":"B275","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1620\/tjem.241.271","article-title":"Early diagnosis of tuberculosis-associated IgA nephropathy with ESAT-6","volume":"241","author":"Zhao","year":"2017","journal-title":"Tohoku J Exp Med."},{"key":"B276","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1177\/0300060518774127","article-title":"Tuberculosis-associated IgA nephropathy","volume":"46","author":"Wang","year":"2018","journal-title":"J Int Med Res."},{"key":"B277","first-page":"21964","article-title":"Roles of mycobacterium tuberculosis ESAT-6 in the development of renal injury","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"B278","doi-asserted-by":"publisher","first-page":"BSR20170021","DOI":"10.1042\/BSR20170021","article-title":"Role of ESAT-6 in renal injury by regulating microRNA-155 expression via TLR4\/MyD88 signaling pathway in mice with Mycobacterium tuberculosis infection","volume":"37","author":"Zhou","year":"2017","journal-title":"Biosci Rep."},{"key":"B279","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/ajt.15220","article-title":"Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: a retrospective cohort analysis","volume":"19","author":"Viana","year":"2019","journal-title":"Am J Transplant."},{"key":"B280","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/DDDT.S10432","article-title":"Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation","volume":"4","author":"Gupta","year":"2010","journal-title":"Drug Des Devel Ther."},{"key":"B281","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3109\/0284186X.2015.1125017","article-title":"Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma","volume":"55","author":"Lee","year":"2016","journal-title":"Acta Oncol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02846\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T20:04:13Z","timestamp":1695499453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02846\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":281,"alternative-id":["10.3389\/fimmu.2019.02846"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02846","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"article-number":"2846"}}